Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

60.23
Delayed Data
As of Aug 03
 +1.27 / +2.15%
Today’s Change
41.72
Today|||52-Week Range
60.34
+42.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues12.5B13.5B14.9B15.7B
 
 
 
 
 
Cost of Goods Sold2.0B2.0B2.2B2.2B
 
 
 
 
 
Depreciation And Amortization468.0M446.4M473.5M495.6M
 
 
 
 
 
 
Operating ExpensesGross Income10.0B11.1B12.3B13.1B
 
 
 
 
 
General Expenses5.8B6.1B6.8B7.0B
 
 
 
 
 
Other Operating Expenses0.000.000.00113.3M
 
 
Research And Development1.7B1.8B2.0B2.3B
 
 
 
 
 
Total Operating Expenses8.3B8.5B9.4B9.8B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income4.1B5.0B5.5B6.0B
 
 
 
 
 
Extraordinary Credit0.000.00144.3M0.00
 
 
Extraordinary Charge-103.9M-258.2M-25.7M-321.0M
 
 
 
 
 
Interest Expense On Debt51.7M10.1M9.8M26.6M
 
 
 
 
 
Equity In Earnings-751.8K0.000.000.00
 
 
Other Expenses80.3M68.5M181.6M418.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.1B4.8B5.8B6.0B
 
 
 
 
 
Income Taxes-907.4M-1.1B-1.3B-1.3B
 
 
 
 
 
Net Income3.2B3.7B4.5B4.7B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.8B2.7B2.7B2.6B
 
 
 
 
 
Shares To Calculate EPS Diluted2.9B2.8B2.7B2.6B
 
 
 
 
 
 
Earnings Per ShareEPS$1.14$1.36$0.34$1.79
 
 
 
 
 
EPS Diluted$1.13$1.35$1.67$1.78